Overview of the Infertile Population Infertility is observed in 10% to 15% of people and constitutes a significant aspect of clinical medicine for many doctors
GLP-1 RAs (Semaglutide , Liraglutide) GLP-1 RAs are generally well tolerated, though gastrointestinal side effects, especially nausea, vomiting, and diarrhea, are common, particularly during dose escalation
Hepatic Steatosis : Recently, a sub-study of the phase 3 clinical trial SURPASS-3 showed that, among patients receiving metformin and/or SGLT2 inhibitors, the addition of tirzepatide (10 or 15 mg) as compared to insulin degludec was able to significantly reduce hepatic fat content (evaluated by magnetic resonance) after 52 weeks of treatment
To apply online, simply click here and fill out our quick application form
Medications for Weight Loss: Zepbound (semaglutide injection): Approved for adults with obesity or overweight conditions and related health issues, Zepbound helps regulate appetite and promote satiety